Skip to main content
SpringerLink
Log in

Amphotericin-B-liposomal/fosmanogepix/ondansetron

Off-label use, non-compliance and various toxicities: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Goggin KP, et al. Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease. Open Forum Infectious Diseases 10 : 1-6, No. 6, Jun 2023. Available from: URL: https://academic.oup.com/ofid/article/10/6/ofad285/7176278

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amphotericin-B-liposomal/fosmanogepix/ondansetron. Reactions Weekly 1965, 35 (2023). https://doi.org/10.1007/s40278-023-43003-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-43003-0

Search

Navigation